You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 231 No. 10, March 10, 1975 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Delayed Idiosyncratic Psychosis With Diphenylhydantoin

Clarence E. McDanal, Jr., MD; William M. Bolman, MD

JAMA. 1975;231(10):1063.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A PATIENT had a delayed idiosyncratic psychosis to diphenylhydantoin sodium. We have not found another case in the medical literature that described this type of reaction to diphenylhydantoin with supportive blood level data. Stevens1 mentioned four reports of epileptic patients with bizarre, psychotic signs and symptoms who were treated with changes in anticonvulsant medication, neuroleptic drugs, and environment. Unfortunately, no anticonvulsant blood levels were mentioned. The side effects of diphenylhydantoin fall into two categories: dose dependency or individual hypersensitivity or idiosyncratic response. Sparberg2 described the medical complications of diphenylhydantoin therapy and concluded that they were diagnostically confusing.

Report of a Case

A 30-year-old mother of three children had had seizures since she was 12 years old but none in the past four years. She received anticonvulsant medications, mephobarbital, 32 mg four times daily, and diphenylhydantoin sodium, 100 mg four times daily. The patient faithfully took the medication; she . . . [Full Text PDF of this Article]


Author Affiliations

From the University of Hawaii School of Medicine (Dr. Bolman), and Leahi Hospital, Honolulu. Dr. McDanal is a Fellow in Child Psychiatry at the University of Hawaii, Honolulu.


Footnotes

The approved nonproprietary name of diphenylhydantoin will be phenytoin when USP 19 becomes official.

Reprint requests to University of Hawaii, School of Medicine, Leahi Hospital, 3675 Kilauea Ave, Honolulu, HI 96816 (Dr. McDanal).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.